PubMed

The median non-prostate cancer survival is more than 10 years for men up to age 80 years who are selected and receive curative radiation treatment for prostate cancer.

Blood PA, Pickles T.

Radiat Oncol. 2007 May 18;2:17.PMID: 17511871 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer.

Fowler FJ Jr, McNaughton Collins M, Albertsen PC, Zietman A, Elliott DB, Barry MJ.

JAMA. 2000 Jun 28;283(24):3217-22.PMID: 10866869 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Do older men benefit from curative therapy of localized prostate cancer?

Alibhai SM, Naglie G, Nam R, Trachtenberg J, Krahn MD.

J Clin Oncol. 2003 Sep 1;21(17):3318-27.PMID: 12947068 [PubMed - indexed for MEDLINE]Related citations

United States radiation oncologists' and urologists' opinions about screening and treatment of prostate cancer vary by region.

McNaughton Collins M, Barry MJ, Zietman A, Albertsen PC, Talcott JA, Walker Corkery E, Elliott DB, Fowler FJ Jr.

Urology. 2002 Oct;60(4):628-33.PMID: 12385923 [PubMed - indexed for MEDLINE]Related citations

The ten-year rule revisited: accuracy of clinicians' estimates of life expectancy in patients with localized prostate cancer.

Krahn MD, Bremner KE, Asaria J, Alibhai SM, Nam R, Tomlinson G, Jewett MA, Warde P, Naglie G.

Urology. 2002 Aug;60(2):258-63.PMID: 12137823 [PubMed - indexed for MEDLINE]Related citations

[Competitive morbidity ant its impact on life expectancy: evaluation and inclusion in the therapeutic decision regarding localized prostatic cancer]

Soulié M, Villers A, Richaud P, Prapotnich D, Ruffion A, Grosclaude P.

Prog Urol. 2001 Dec;11(6):1195-204. Review. French. PMID: 11859652 [PubMed - indexed for MEDLINE]Related citations

Accuracy of survival prediction by palliative radiation oncologists.

Chow E, Davis L, Panzarella T, Hayter C, Szumacher E, Loblaw A, Wong R, Danjoux C.

Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):870-3.PMID: 15708268 [PubMed - indexed for MEDLINE]Related citations

Improved biochemical disease-free survival of men younger than 60 years with prostate cancer treated with high dose conformal external beam radiotherapy.

Zelefsky MJ, Marion C, Fuks Z, Leibel SA.

J Urol. 2003 Nov;170(5):1828-32.PMID: 14532785 [PubMed - indexed for MEDLINE]Related citations

Asian race and impact on outcomes after radical radiotherapy for localized prostate cancer.

Man A, Pickles T, Chi KN; British Columbia Cancer Agency Prostate Cohort Outcomes Initiative.

J Urol. 2003 Sep;170(3):901-4.PMID: 12913726 [PubMed - indexed for MEDLINE]Related citations

Effect of obesity on prostate-specific antigen recurrence after radiation therapy for localized prostate cancer as measured by the 2006 Radiation Therapy Oncology Group-American Society for Therapeutic Radiation and Oncology (RTOG-ASTRO) Phoenix consensus definition.

Stroup SP, Cullen J, Auge BK, L'Esperance JO, Kang SK.

Cancer. 2007 Sep 1;110(5):1003-9.PMID: 17614338 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

A prospective survey of radiotherapy in Sweden.

[No authors listed]

Acta Oncol. 1996;35 Suppl 6:47-56.PMID: 9154085 [PubMed - indexed for MEDLINE]Related citations

Treatment and survival outcomes in young men diagnosed with prostate cancer: a Population-based Cohort Study.

Lin DW, Porter M, Montgomery B.

Cancer. 2009 Jul 1;115(13):2863-71.PMID: 19466697 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

[Do older men with localized prostate cancer Gleason 8-10 benefit from curative therapy?]

Ojea Calvo A, López García S, Rey Rey J, Alonso Rodrigo A, Rodríguez Iglesias B, Barros Rodríguez JM.

Actas Urol Esp. 2008 Jun;32(6):589-93. Spanish. PMID: 18655341 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Is there age bias in the treatment of localized prostate carcinoma?

Alibhai SM, Krahn MD, Cohen MM, Fleshner NE, Tomlinson GA, Naglie G.

Cancer. 2004 Jan 1;100(1):72-81.PMID: 14692026 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Residual prostate cancer after radiotherapy: a study of radical cystoprostatectomy specimens.

Kaplan DJ, Crispen PL, Greenberg RE, Chen DY, Viterbo R, Buyyounouski MK, Horwitz EM, Uzzo RG.

Urology. 2008 Sep;72(3):654-8. Epub 2008 Mar 4.PMID: 18289645 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

Biochemical disease-free survival in men younger than 60 years with prostate cancer treated with external beam radiation.

Rosser CJ, Chichakli R, Levy LB, Kuban DA, Smith LG, Pisters LL.

J Urol. 2002 Aug;168(2):536-41.PMID: 12131304 [PubMed - indexed for MEDLINE]Related citations

Factors associated with initial therapy for clinically localized prostate cancer: prostate cancer outcomes study.

Harlan LC, Potosky A, Gilliland FD, Hoffman R, Albertsen PC, Hamilton AS, Eley JW, Stanford JL, Stephenson RA.

J Natl Cancer Inst. 2001 Dec 19;93(24):1864-71.PMID: 11752011 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Decision analyses in consideration of treatment strategies for patients with biochemical failure after curative therapy on clinically localized prostate cancer in the prostate-specific antigen era.

Shimizu F, Igarashi A, Fukuda T, Kawachi Y, Minowada S, Ohashi Y, Fujime M.

Jpn J Clin Oncol. 2007 Oct;37(10):763-74. Epub 2007 Oct 22.PMID: 17956899 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists.

Fowler FJ Jr, Bin L, Collins MM, Roberts RG, Oesterling JE, Wasson JH, Barry MJ.

Am J Med. 1998 Jun;104(6):526-32.PMID: 9674714 [PubMed - indexed for MEDLINE]Related citations

Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome.

Ward JF, Slezak JM, Blute ML, Bergstralh EJ, Zincke H.

BJU Int. 2005 Apr;95(6):751-6.PMID: 15794776 [PubMed - indexed for MEDLINE]Related citations